CH626919A5 - - Google Patents

Download PDF

Info

Publication number
CH626919A5
CH626919A5 CH36277A CH36277A CH626919A5 CH 626919 A5 CH626919 A5 CH 626919A5 CH 36277 A CH36277 A CH 36277A CH 36277 A CH36277 A CH 36277A CH 626919 A5 CH626919 A5 CH 626919A5
Authority
CH
Switzerland
Prior art keywords
thrombin
iii
solution
heparin
determination
Prior art date
Application number
CH36277A
Other languages
German (de)
English (en)
Inventor
Hermann Erich Dr Karges
Norbert Dr Heimburger
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of CH626919A5 publication Critical patent/CH626919A5/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/75Fibrin; Fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121Serpins
    • G01N2333/8128Antithrombin III
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974Thrombin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CH36277A 1976-01-15 1977-01-12 CH626919A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2601372A DE2601372C3 (de) 1976-01-15 1976-01-15 Verfahren zur Bestimmung von Antithrombin III

Publications (1)

Publication Number Publication Date
CH626919A5 true CH626919A5 (xx) 1981-12-15

Family

ID=5967533

Family Applications (1)

Application Number Title Priority Date Filing Date
CH36277A CH626919A5 (xx) 1976-01-15 1977-01-12

Country Status (13)

Country Link
US (1) US4106990A (xx)
JP (1) JPS6033480B2 (xx)
AT (1) AT350193B (xx)
AU (1) AU515025B2 (xx)
BE (1) BE850453A (xx)
CA (1) CA1079166A (xx)
CH (1) CH626919A5 (xx)
DE (1) DE2601372C3 (xx)
DK (1) DK15077A (xx)
ES (1) ES455030A1 (xx)
FR (1) FR2338496A1 (xx)
GB (1) GB1569392A (xx)
ZA (1) ZA77210B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2812943C3 (de) * 1978-03-23 1981-05-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma
US4302538A (en) * 1978-03-27 1981-11-24 Ortho Diagnostics Inc. Buffer system in an anti-thrombin III test
US4195072A (en) * 1978-07-05 1980-03-25 Abbott Laboratories Stabilized platelet factor 4 immunoassay standards
DE2903701C2 (de) * 1979-01-31 1980-10-16 Boehringer Mannheim Gmbh, 6800 Mannheim Kontrollreagens für die Bestimmung der Heparinaktivität
SE422081B (sv) * 1979-08-22 1982-02-15 Ird Biomaterial Ab Sett att pavisa proteolytiska enzymer
WO1982001377A1 (en) * 1980-10-09 1982-04-29 Lill Helmut Method for determining a bm-antithrombin
US5221614A (en) * 1988-03-03 1993-06-22 Nippon Shoji Kabushiki Kaisha Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
EP1045250A1 (en) * 1999-04-12 2000-10-18 INSTRUMENTATION LABORATORY S.p.A. A global test for evaluating the functionality of the thrombin/antithrombin system
US6432658B1 (en) 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
JP6278454B2 (ja) * 2013-03-29 2018-02-14 株式会社Lsiメディエンス 生体試料中の直接トロンビン阻害薬の測定試薬及び測定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3497319A (en) * 1966-11-02 1970-02-24 Pfizer & Co C Diagnostic reagent
US3853710A (en) * 1973-01-15 1974-12-10 Ass For Pharmacologic Res Inc Serum diagnostic test for maladies causing change in fibrinolytic activity in the blood
US3985618A (en) * 1975-05-02 1976-10-12 Irving Innerfield Method for detection of thrombosis and prethrombosis

Also Published As

Publication number Publication date
CA1079166A (en) 1980-06-10
AU515025B2 (en) 1981-03-12
JPS6033480B2 (ja) 1985-08-02
DE2601372A1 (de) 1977-07-28
ES455030A1 (es) 1978-04-01
DK15077A (da) 1977-07-16
JPS5288094A (en) 1977-07-22
ATA18877A (de) 1978-10-15
FR2338496B1 (xx) 1983-01-28
GB1569392A (en) 1980-06-11
US4106990A (en) 1978-08-15
FR2338496A1 (fr) 1977-08-12
AT350193B (de) 1979-05-10
BE850453A (fr) 1977-07-18
AU2129277A (en) 1978-07-20
ZA77210B (en) 1977-12-28
DE2601372B2 (de) 1979-07-19
DE2601372C3 (de) 1980-03-27

Similar Documents

Publication Publication Date Title
EP0137269B1 (de) Verfahren zur gleichzeitigen Bestimmung von Fibrinogen und Fibrinogen-Spaltprodukten im Plasma
DE2812943C3 (de) Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma
EP1734369B1 (de) Verfahren zur Standardisierung von Gerinnungstesten
EP0915340B1 (de) Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe und Verfahren zur Bestimmung der Glykosilierung von Thrombomodulin
DE60315151T2 (de) Diagnostischer test zur bestimmung der konzentration einer transienten proteolytischen aktivität in zusammengesetzten biologischen medien
EP0012184B1 (de) Hämolysierlösung, Verwendung einer solchen für die Bestimmung von Glucose im Blut, und Hämolyseverfahren
DE2601372C3 (de) Verfahren zur Bestimmung von Antithrombin III
EP0120220B1 (de) Verfahren und Reagenz zur Glucosebestimmung im hämolysierten Blut
DE112006003476T5 (de) Verfahren und Systeme zum Nachweisen und Quantifizieren indirekter Thrombininhibitoren
DE4427785A1 (de) Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
Ødegård et al. 2.7 Determination of Antithrombin III and Antifactor X a Activity
DE60032001T2 (de) Verfahren zur stabilisierung von thrombin
DE69013834T2 (de) Reagenz zum Nachweis und zur quantitativen Bestimmung von Leukozyten in biologischen Flüssigkeiten und Verfahren zu seiner Verwendung.
EP0185335B1 (de) Verfahren zum Nachweis des Vorliegens einer Allergie und zum spezifischen Nachweis des für die Allergie verantwortlichen Allergens
DE3430906A1 (de) Verfahren zur bestimmung von fibrinmonomer in plasma
DE69016858T2 (de) Verfahren und Reagenziensatz zur Bestimmung der funktionalen Aktivität von Protein S in menschlichem Plasma.
DE2654189C3 (de) Verfahren zur in-vitro-Bestimmung der biologischen Aktivität von Faktor Xa-Inhibitor im Blut
EP0062310A1 (de) Reagens zur optischen Bestimmung des Blutgerinnungsverhaltens
EP0408075B1 (de) Verfahren und Reagenz zur Bestimmung von Antithrombin III
EP0711839B1 (de) Kalibrator zur Verwendung in Testverfahren zum Nachweis eines defekten Gerinnungsfaktors V
AT399055B (de) Verfahren zur bestimmung von fibrinogen
DE4402631A1 (de) Verfahren zur Bestimmung von Gerinnungsparametern
EP0445626A2 (de) Funktioneller Test zur Bestimmung der Protein S-AktivitÀ¤t
DE69916816T2 (de) Verbesserter blutgerinnungstest
DE1943881C3 (de) Verfahren zur quantitativen Bestimmung der Thrombinaktivität in Blutplasma und dessen Fraktionen

Legal Events

Date Code Title Description
PL Patent ceased